VEGFA and cancer: Combining antivascular endothelial growth factor (VEGF)/vascular endothelial growth factor receptor (VEGFR) agents with checkpoint blockade, emerged as a viable strategy to advance the immunotherapy paradigm.[15] VEGF is a prime example of signaling pathways promoting cancer treatment escape.